117546-56-2

Basic information

• Product Name: 3-AzetidinaMine, 1-(1-Methylethyl)-, hydrochloride (1:2)
• Synonyms: 3-AzetidinaMine, 1-(1-Methylethyl)-, hydrochloride (1:2);1-(propan-2-yl)azetidin-3-amine dihydrochloride;1-Isopropylazetidin-3-amine dihydrochloride;1-(1-Methylethyl)-3-azetidinamine,hydrochloride(1:2);1-Isopropyl-azetidin-3-ylamine dihydrochloride;1-(PROPAN-2-YL)AZETIDIN-3-AMINE 2HCL
• CAS NO: 117546-56-2
• Molecular Formula: C6H16Cl2N2
• Molecular Weight: 187.11
• Mol File: 117546-56-2.mol
• Article Data: 3

Chemical Properties

• Appearance: /
• CAS DataBase Reference: 3-AzetidinaMine, 1-(1-Methylethyl)-, hydrochloride (1:2)(CAS DataBase Reference)
• NIST Chemistry Reference: 3-AzetidinaMine, 1-(1-Methylethyl)-, hydrochloride (1:2)(117546-56-2)
• EPA Substance Registry System: 3-AzetidinaMine, 1-(1-Methylethyl)-, hydrochloride (1:2)(117546-56-2)

Safety Data

• Hazardous Substances Data: 117546-56-2(Hazardous Substances Data)

Usage

General Description

3-AzetidinaMine, 1-(1-Methylethyl)-, hydrochloride (1:2) is a chemical compound that consists of a azetidin-3-amine molecule that is hydrochloride salt with a 1:2 ratio. It is also known as N-isopropylazetidine hydrochloride. 3-AzetidinaMine, 1-(1-Methylethyl)-, hydrochloride (1:2) is used in the synthesis of various pharmaceutical drugs and is also utilized as an intermediate in organic synthesis. It is a white to off-white crystalline powder that is soluble in water and methanol. 3-AzetidinaMine, 1-(1-Methylethyl)-, hydrochloride (1:2) has potential applications in the pharmaceutical and chemical industries due to its versatile properties and uses.

Upstream product

• 1210273-37-2 tert-butyl 3-aminoazetidine-1-carboxylate hydrochloride 
• 193269-78-2 3-aminoazetidine-1-carboxylic acid tert-butyl ester 
• 67-64-1 acetone 

Relevant articles and documents

Optimization of a kilogram-scale synthesis of a potent cycloartenol triterpenoid-derived γ-secretase modulator

This work describes the demonstration of a kilogram-scale synthesis of a γ-secretase modulator from a plant-sterol-derived starting material. Key to developing a synthetic route capable of delivering a kilogram of the target compound was the development of a four-reaction telescope process and a selective O-alkylation of a triol intermediate. These improvements enabled the successful delivery of kilogram-scale batches of API for preclinical development studies.

COMPOUNDS USEFUL FOR TREATING NEURODEGENERATIVE DISORDERS

The present invention provides compounds useful for treating or lessening the severity of a neurodegenerative disorder. The present invention also provides methods of treating or lessening the severity of such disorders wherein said method comprises administering to a patient a compound of the present invention, or composition thereof. Said method is useful for treating or lessening the severity of, for example, Alzheimer’s disease.